Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | NR3C1 | P04150 | 7/20 | 0.49 |
| ▸ | PGR | P06401 | 4/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.49 |
| ▸ | USP2 | O75604 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | MLNR | O43193 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3765710 | 1.00 | CYP3A4 (0.50) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL3754453 | 0.94 | CYP3A4 (0.51) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL3754454 | 0.94 | CYP3A4 (0.51) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL13051217 | 0.93 | CYP3A4 (0.50) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL2707624 | 0.91 | NR3C1 (0.52) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL3765653 | 0.91 | NR3C1 (0.52) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL3762018 | 0.91 | CYP3A4 (0.48) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL3762015 | 0.91 | CYP3A4 (0.48) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL12996701 | 0.91 | CYP3A4 (0.51) | CYP3A4LMNAHIF1AALDH1A1NR3C1 | |
| SCHEMBL3760132 | 0.88 | NR3C1 (0.48) | CYP3A4LMNAHIF1AALDH1A1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100303758-A1 | Novel Glucocorticoid Receptor Agonists | GLOSSOP PAUL ALAN | 2010-12-02 | — | — | US | claimed |
| US-20100303758-A1 | Novel Glucocorticoid Receptor Agonists | GLOSSOP PAUL ALAN | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100303758-A1 | Novel Glucocorticoid Receptor Agonists | NR3C1, NR3C2, MC2R | CYP3A4 678/4885LMNA 4558/4885HIF1A 1893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.